MedTrace Logo

A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

NCT06891222 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10500

Last updated 2025-05-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.

Conditions

  • Cardiac Disease

Interventions

DIAGNOSTIC_TEST

AI-ECG (artificial intelligence-enabled electrocardiogram)

Participants will undergo electrocardiogram analysis using AI-ECG during the baseline visit

DIAGNOSTIC_TEST

Focus Screening (focused cardiac ultrasonography)

Participants will undergo a focused cardiac ultrasound if the AI-ECG reflects a positive value

Sponsors & Collaborators

Principal Investigators

  • Gal Tsaban, M.D., Ph.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-14
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06891222 on ClinicalTrials.gov